Does acute endogenous hyperprolactinemia affect intravenous glucose tolerance in humans?

Area of Science:

• Endocrinology
• Metabolism
• Human Physiology

Background:

• Hyperprolactinemia, a condition of elevated prolactin levels, is common.
• The impact of acute endogenous hyperprolactinemia on glucose metabolism in humans is not well understood.

Purpose of the Study:

• To investigate the influence of acute endogenous hyperprolactinemia on glucose tolerance in healthy subjects and type 2 diabetes patients.
• To compare glucose disappearance rates under normoprolactinemic and hyperprolactinemic conditions.

Main Methods:

• Two intravenous glucose tolerance tests (IVGTTs) were conducted in participants.
• Hyperprolactinemia was induced using metoclopramide (MET); normoprolactinemia was achieved with placebo.
• Glucose disappearance rates (Kg) were measured and compared between conditions.

Main Results:

• In healthy subjects with initially good glucose tolerance, MET-induced hyperprolactinemia significantly decreased glucose disappearance rates (Kg).
• The observed decrease in Kg was not attributable to changes in insulin, cortisol, or growth hormone levels.
• Metoclopramide alone did not affect Kg when hyperprolactinemia was blocked by bromocriptine.

Conclusions:

• Acute endogenous hyperprolactinemia can impair glucose tolerance in humans.
• Elevated prolactin levels may negatively impact glucose metabolism independently of other hormonal changes.
• Further research is warranted to elucidate the mechanisms underlying prolactin's effect on glucose homeostasis.